Finance

Lists
Why is ACH down 12,30%?
Dive Deeper
ACH:NYSE
Accendra Health Inc
USD 0,20
-12,30%
(-0,029) 1D
19 Okt., 14:57:28 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACH...
Open
USD 0,24
High
USD 0,25
Low
USD 0,20
Mkt. cap
15,37 m
Avg. vol.
1,60 m
Volume
2,51 m
52-wk high
USD 4,69
52-wk low
USD 0,20
EPS
-USD 3,93
Beta
1,57
Shares outstanding
76,90 m
No. of employees
6 k
Open
USD 0,24
High
USD 0,25
Low
USD 0,20
Mkt. cap
15,37 m
Avg. vol.
1,60 m
Volume
2,51 m
52-wk high
USD 4,69
52-wk low
USD 0,20
EPS
-USD 3,93
Beta
1,57
Shares outstanding
76,90 m
No. of employees
6 k
News stories
From web sources and news partners
Profile
Accendra Health is a global healthcare company. It employs over 20,000 people in 70 countries. A Fortune 500 company, it was founded in 1882 in Richmond, Virginia, where it remains headquartered. The company has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. President and CEO Ed Pesicka joined Owens & Minor in March 2019. Wikipedia
About Accendra Health Inc
CEOEdward A Pesicka
Employees6,5 k
Founded1882
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 5 analysts giving stock ratings to ACH in the past 3 months
Hold
Buy
0
Hold
4
Sell
1
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ACH in the last 3 months.
Highest
Current USD 0,20
USD 1,50 (+631,71%)
Average
USD 1,45 (+607,32%)
Lowest
USD 1,30 (+534,15%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Cherny
Leerink Partners
Hold
Reiterated
-
-
09/18/2026
Kevin Caliendo
UBS
Hold
Maintained
USD 1,50
+631,7%
08/13/2026
Allen Lutz
Bank of America Securities
Sell
Maintained
USD 1,30
+534,1%
08/11/2026
Eric Coldwell
Robert W. Baird
Hold
Downgraded
USD 1,50
+631,7%
08/11/2026
Daniel Grosslight
Citi
Hold
Downgraded
USD 1,50
+631,7%
08/11/2026
Next call oor 10 dae
Do. 29 Okt., 23:00
Fiscal period
Q3 2026
- / -USD 0,09
Revenue / Est. (USD)
- / 617,38 m
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
697,26 m
708,97 m
627,78 m
613,23 m
Cost of goods sold
375,07 m
385,71 m
349,75 m
349,83 m
Cost of revenue
375,07 m
385,71 m
349,75 m
349,83 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
265,84 m
273,20 m
255,23 m
243,56 m
Operating expense
265,84 m
302,42 m
284,46 m
272,79 m
Total operating expenses
640,90 m
688,13 m
634,21 m
622,62 m
Operating income
56,36 m
20,83 m
-6,43 m
-9,38 m
Other non operating income
-1,08 m
747,00 k
-1,02 m
-643,00 k
EBT including unusual items
-3,64 m
-7,97 m
-16,25 m
-87,63 m
EBT excluding unusual items
26,25 m
-6,35 m
-39,80 m
-44,56 m
Income tax expense
1,97 m
1,47 m
-9,78 m
1,44 m
Effective tax rate
-54,25%
-18,47%
60,19%
-1,65%
Other operating expenses
-
-
-
-
Net income
-150,28 m
-56,33 m
-6,47 m
-89,07 m
Net profit margin
-21,55%
-7,94%
-1,03%
-14,52%
Earnings per share
0,25
0,21
-0,04
-0,19
Interest and investment income
-
-
-
-
Interest expense
-29,03 m
-27,93 m
-32,35 m
-34,54 m
Net interest expenses
-29,03 m
-27,93 m
-32,35 m
-34,54 m
Depreciation and amortization charges
-
-
-
-
EBITDA
120,46 m
50,71 m
55,32 m
56,32 m
Gain or loss from assets sale
-7,06 m
-10,89 m
-55,51 m
-3,27 m
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme